PIETTE YVES
0841.560.815 · rovalta.com · 25/09/2026
PIETTE YVES
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPIETTE YVES is a Private limited company incorporated in 2011. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Jabbeke.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0841.560.815
- Incorporation
- 05/12/2011
- Legal form
- Private limited company
- Registered office
- Kerkeweg 63
8490 Jabbeke · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 185,6 k € | -2.1% | 189,6 k € | -9.2% | 208,9 k € | +17.6% | 177,7 k € | +15.5% | 153,8 k € |
| EBITDA | 180,1 k € | -1.5% | 182,8 k € | -10.3% | 203,8 k € | +17.0% | 174,2 k € | +14.8% | 151,7 k € |
| Operating result | 164,4 k € | -1.7% | 167,3 k € | -12.2% | 190,6 k € | +18.2% | 161,3 k € | +136% | 68,2 k € |
| Net result | 105,4 k € | +1.7% | 103,6 k € | -14.8% | 121,6 k € | -10.4% | 135,7 k € | +615% | 19 k € |
| Balance sheet | |||||||||
| Equity | 662,2 k € | +3.4% | 640,4 k € | +18.9% | 538,5 k € | +8.8% | 495,1 k € | +21.9% | 406,1 k € |
| Total assets | 1,1 M € | +8.4% | 969,7 k € | -0.2% | 971,2 k € | +8.9% | 891,9 k € | +21.8% | 732,2 k € |
| Cash | 131,3 k € | +34.9% | 97,3 k € | +24.4% | 78,2 k € | -47.7% | 149,4 k € | +0.6% | 148,6 k € |
| Debts | 388,8 k € | +18.1% | 329,3 k € | -23.9% | 432,7 k € | +9.1% | 396,6 k € | +21.7% | 326 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 2 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 28/07/2026 | 24/07/2025 | 27/06/2024 | 20/07/2023 | 30/08/2022 | 29/07/2021 |
| General meeting | 30/06/2026 | 26/06/2025 | 20/06/2024 | 24/06/2023 | 30/06/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/06/2026 | 28/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 26/06/2025 | 24/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 20/06/2024 | 27/06/2024 | Dutch | |
| Abridged model | 31/12/2022 | 24/06/2023 | 20/07/2023 | Dutch | |
| Micro model | 31/12/2021 | 30/06/2022 | 30/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 30/06/2021 | 29/07/2021 | Dutch | |
| Micro model | 31/12/2019 | 31/07/2020 | 31/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 30/06/2019 | 19/07/2019 | Dutch | |
| Micro model | 31/12/2017 | 30/06/2018 | 30/07/2018 | Dutch | |
| Micro model | 31/12/2016 | 30/06/2017 | 28/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 30/06/2016 | 29/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 27/06/2015 | 14/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 28/06/2014 | 24/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 29/06/2013 | 03/07/2013 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates06/02/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN
- Mandates27/09/2023ONTSLAGEN - BENOEMINGEN
- Registered office01/04/2015MAATSCHAPPELIJKE ZETEL
- Other15/12/2011RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025105,4 k €↑
- 2024Annual accounts 2024103,6 k €↓
- 2023Annual accounts 2023121,6 k €↓
- 2023Name changePiette Yves
- 2022Annual accounts 2022135,7 k €↑
- 2021Annual accounts 202119 k €↓
- 2020Annual accounts 202071,4 k €↓
- 2019Annual accounts 201983,5 k €↑
- 2018Annual accounts 201878,2 k €↑
- 2017Annual accounts 201747,5 k €↓
- 2016Annual accounts 201671,9 k €↑
- 2015Annual accounts 201571,4 k €↑
- 2014Annual accounts 201452 k €↓
- 2013Annual accounts 201353 k €↑
- 2012Annual accounts 201221,5 k €
- 2012Name changePiette Yves Reumatologie
- 05/12/2011IncorporationPrivate limited company